Persistent URL of this record https://hdl.handle.net/1887/44019
Documents
-
- Download
- Title Pages_Contents
- open access
-
- Download
- Part I: Chapter 2
- open access
- Full text at publishers site
-
- Download
- Part I: Chapter 3
- open access
- Full text at publishers site
-
- Download
- Part I: Chapter 4
- open access
- Full text at publishers site
-
- Download
- Part I: Chapter 5
- open access
- Full text at publishers site
-
- Download
- Part I: Chapter 6
- open access
- Full text at publishers site
-
- Download
- Part I: Chapter 7
- open access
-
- Download
- Part II: Chapter 8
- open access
- Full text at publishers site
-
- Download
- Part II: Chapter 9
- open access
- Full text at publishers site
-
- Download
- Part II: Chapter 10
- open access
-
- Download
- Part II: Chapter 11
- open access
- Full text at publishers site
-
- Download
- Part II: Chapter 12
- open access
- Full text at publishers site
-
- Download
- Part II: Chapter 13
- open access
- Full text at publishers site
-
- Download
- Part II: Chapter 14
- open access
- Full text at publishers site
-
- Download
- Part III: Chapter 15
- open access
- Full text at publishers site
-
- Download
- Part III: Chapter 16
- open access
- Full text at publishers site
-
- Download
- Part III: Chapter 17
- open access
-
- Download
- Part III: Chapter 18
- open access
-
- Download
- Propositions
- open access
In Collections
This item can be found in the following collections:
The course of clinically suspect arthralgia and early rheumatoid arthritis : clinical features, imaging and genetics
The severity of the course of RA is variable between patients and this cannot be yet...Show more The field of rheumatoid arthritis (RA) is moving into identification of patients as early as possible and the ultimate aim is to prevent RA becoming a chronic disease. To this end, we studied the phase of Clinically Suspect Arthralgia (CSA). Patients with arthralgia that were considered by the rheumatologist to have an increased risk to progress to RA (CSA) had indeed an increased risk of RA. In addition, subclinical MRI-inflammation preceded clinical arthritis with a few months. Future research will shed more light on processes underlying progression from CSA to RA and effectiveness of treatment initiation in the CSA phase.
The severity of the course of RA is variable between patients and this cannot be yet accurately predicted. In this thesis, we performed studies that contributed to the understanding of these differences in severity. Three genetic risk factors for more severe joint damage progression (two non-HLA and one HLA variation) and one for arthritis persistence were identified. Further research on functional implications of the identified variants and whether they might be useful as biomarkers to guide treatment decisions is needed.Show less
- All authors
- Steenbergen, H.W. van
- Supervisor
- Huizinga, T.W.J.; Helm-van Mil, A.H.M. van der
- Committee
- Kloppenburg, G.; Landewé, R.B.M.; Houwing-Duistermaat, J.; Hazes, M.
- Qualification
- Doctor (dr.)
- Awarding Institution
- Faculty of Medicine, Leiden University Medical Center (LUMC), Leiden University
- Date
- 2016-11-08
- ISBN (print)
- 9789462333307
Funding
- Sponsorship
- Reumafonds, Stichting MCH en Bronovo-Nebo, Pfizer BV, AbbVie BV, UCB Pharma BV en Chipsoft.